$66.33
0.350.53%
At close: -
$66.33
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
ANI Pharmaceuticals Stock Guidance | NASDAQ:ANIP | Benzinga
ANI Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/28/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | $6.12 | $6.49 | $5.56 | $756.00M | $776.00M | $724.88M | Get Alert |
| 01/13/2025 | ANIP | ANI Pharmaceuticals | FY | 2025 | — | — | — | $739.00M | $759.00M | $720.30M | Get Alert |
| 11/08/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.90 | $5.05 | $4.72 | $594.00M | $602.00M | $590.31M | Get Alert |
| 08/06/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.38 | $4.82 | $4.49 | $540.00M | $560.00M | $554.60M | Get Alert |
| 05/14/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | — | — | — | $520.00M | $542.00M | $513.14M | Get Alert |
| 05/10/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.48 | $520.00M | $542.00M | $535.11M | Get Alert |
| 04/17/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.47 | $520.00M | $542.00M | $534.15M | Get Alert |
| 03/12/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.46 | $520.00M | $542.00M | $535.28M | Get Alert |
| 02/29/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.33 | $520.00M | $542.00M | $501.09M | Get Alert |
| 11/08/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $4.29 | $4.57 | $4.08 | $468.00M | $478.00M | $452.94M | Get Alert |
| 09/12/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.97 | $425.00M | $445.00M | $442.97M | Get Alert |
| 08/30/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.97 | $425.00M | $445.00M | $442.97M | Get Alert |
| 08/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.31 | $425.00M | $445.00M | $406.41M | Get Alert |
| 06/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | — | — | — | $385.00M | $410.00M | $403.52M | Get Alert |
| 05/08/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $2.99 | $3.45 | $2.43 | $385.00M | $410.00M | $361.82M | Get Alert |
| 03/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $2.09 | $2.59 | $2.62 | $360.00M | $385.00M | $352.49M | Get Alert |
| 11/09/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.37 | $295.00M | $315.00M | $302.88M | Get Alert |
| 08/08/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.43 | $295.00M | $315.00M | $304.50M | Get Alert |
| 05/10/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.15 | $295.00M | $315.00M | $292.77M | Get Alert |
| 03/15/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | — | — | — | $260.00M | $275.00M | $301.57M | Get Alert |
FAQ
What is the most recent guidance for ANI Pharmaceuticals (ANIP)?
The most recent guidance for ANI Pharmaceuticals (ANIP) was reported on February 28, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $6.12 to $6.49, compared to the estimated EPS of $5.56. Additionally, ANI Pharmaceuticals forecasted revenue between $0.76B and $0.78B for the quarter.
Browse guidance and forecast on all stocks.